Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. The compound (a sesquiterpene lactone) is isolated from the plant Artemisia annua. Not all plants of this species contain artemisinin.
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.
A review of previous studies indicates that two doses of a malaria preventive therapy during pregnancy provides substantial benefit to HIV-negative women in Africa, with more frequent dosing apparently necessary for HIV-positive women, according to an article in the June 20 issue of JAMA.
Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades.
Despite improvements in the ability to diagnose malaria, these diagnostic tests are often underused in Zambia, and patients with negative test results are often prescribed anti-malaria medications, according to a study in the May 23/30 issue of JAMA , a theme issue on malaria.
Johns Hopkins University researchers have cured malaria-infected mice with single shots of a new series of potent, long lasting synthetic drugs modeled on an ancient Chinese herbal folk remedy.
The World Health Organization (WHO) has published guidelines for the cultivation and collection of Artemisia (Artemisia annua L., Asteraceae), known in the United States as sweet Annie or annual wormwood, a Chinese traditional medicinal plant which is the source of artemisinin, used to produce the most effective medicines for malaria.
New technologies that make the large-scale extraction of a natural antimalarial ‘wonder drug' both cheaper and greener are to be developed and trialled in a new European effort.
The World Health Organisation (WHO) says regardless of promises of better healthcare by governments and donor countries, millions of mothers, newborn babies and children continue to die each year in Africa from preventable diseases.
The signs are everywhere, across the continent: Africa is finding African approaches to solving its health problems.
Nearly thirty years after phasing out the widespread use of indoor spraying with DDT and other insecticides to control malaria, the World Health Organization (WHO) has announced that this intervention will once again play a major role in its efforts to fight the disease.
Roll Back Malaria Partners are supporting mass distribution of malaria bednets to prevent hundreds of thousands of deaths from malaria in many endemic countries.
The World Health Organisation (WHO) is quite rightly patting itself on the back because it has persuaded as many as 13 drug companies to abandon the marketing and promotion of monotherapy in the treatment of Malaria.
Following pressure from the World Health Organization (WHO), 13 pharmaceutical companies have agreed to comply with their recommendation that single-drug artemisinin medicines for the oral treatment of malaria need to be phased out.
U.S. researchers say a cheap way to produce an expensive but effective malaria drug is well on the way.
The World Health Organization (WHO) has issued new guidelines concerning the use of the malaria drug Artemisinin.
A British university will benefit from a donation from Bill and Melinda Gates to the tune of £28 million as part of a £145 million gift to malaria research worldwide.
Despite changes in policy in many African countries, most cases of malaria are still treated with old drugs that often fail, say researchers the British Medical Journal.
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
If used alone, artemisinins will cure the most severe type of malaria - falciparum malaria - in seven days. However, when used on their own, they have a high risk of the malaria coming back and hence must be combined with other antimalarials to work best.
According to new report by the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF), progress has been made in preventing and treating malaria since 2000 and more countries are introducing the latest preventative measures to beat the disease.